GeoVax, Inc. @Geovax_News Twitter profile

Pinned Tweet

GeoVax, Inc.

@Geovax_News

3 months

2

4

17

Last Seen Profiles

@bntjyzn7

@Darkside973

@signorelli195

@CGHIRSCHFELD

@sibumaiti

@SmilecontactR

@simo_furi

@TeekayyTV

@eloisacamcd

@EYFSlove2learn

@FCB__Hani

@soap_ear

@VmaniakJ

@bokeplokalmalam

@gokulam49

@7H_malla

@miyu_kiyohara

@zackemusik

@flokosH

@poker10com

@neneha2525

@Seabeazley

@beafandraw

@ItTakesAnSmp

@UilleamUan

@hayufan

@xngshncisu23925

@Ascend_Coin

@eonwndr

@kazyu_2222

@tamatert212

@ukumbushoJr

@ominbeann

@omneshomines

@Gayass

@nexai

GeoVax, Inc.

@Geovax_News

4 years

TV Interview with Maria Bartiromo - GeoVax CEO David Dodd discusses his company's working with a Chinese company to develop a coronavirus vaccine. #COVID -19 #coronavirus #infectiousdiseases #vaccines $GOVX @MorningsMaria @FoxBusiness @MariaBartiromo

8

14

86

GeoVax, Inc.

@Geovax_News

4 years

The GOVX-B11 vaccine for HIV has demonstrated outstanding safety and immunogenicity. #vaccine #development #HIV #immunogenicity $GOVX

1

17

49

GeoVax, Inc.

@Geovax_News

5 years

The U.S. Army is funding the GeoVax's preclinical work for the Lassa Fever Vaccine Program Funding the dev and evaluation through non-human primate studies + production of vaccine material for potential human trials #Lassafever $GOVX @USArmy

3

7

24

GeoVax, Inc.

@Geovax_News

2 years

Pre-clinical data demonstrates single dose protection and potency of the MVA-VLP platform for use in emergency situations to contain outbreaks. #vaccine #MVA #SudanEbolavirus #infectiousdisease #singledose @NaturePortfolio $GOVX

0

4

24

GeoVax, Inc.

@Geovax_News

2 years

GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update #vaccine #COVID19 #immunocompromised #TCells #infectiousdisease #immunotherapy $GOVX

0

3

21

GeoVax, Inc.

@Geovax_News

2 years

Analysis of Phase 1 data showed that GEO-CM04S1 demonstrated potent and equivalent T-cell cross-reactivity against delta and omicron variants. #COVID19 #vaccine #variants #TCells #data @CellPressNews $GOVX

0

4

22

GeoVax, Inc.

@Geovax_News

2 years

The MVA vaccine platform was originally used to develop smallpox vaccines for people with weakened immune systems. #MVA #vaccine #smallpox #monkeypox #COVID19 #immunesystem @biztv @biztalkradio $GOVX

0

3

23

GeoVax, Inc.

@Geovax_News

5 years

To the body, GeoVax's VLP antigens look like the naturally-occurring infection. This initiates both cellular and humoral immune response, resulting in a specific and robust immunity that is rapid-acting and highly durable. #VLP #virus #immunity $GOVX

1

14

20

GeoVax, Inc.

@Geovax_News

2 years

John Sharkey, Ph.D., discusses GeoVax's transition to a Phase II company. #vaccine #COVID19 #immunooncology #phase2 #biotech #growth @GailLdutton @biospace

0

6

22

GeoVax, Inc.

@Geovax_News

5 years

GeoVax and BravoVax (Wuhan, China) Collaborating on the Development of Coronavirus Vaccine #coronavirus #collaboration #groundzero #vaccine $GOVX $GOVXD #BravoVax

3

13

20

GeoVax, Inc.

@Geovax_News

2 years

GeoVax Receives Notice of Allowance for Zika Vaccine Patent #infectiousdisease #Zika #Virus #vaccine $GOVX

0

5

19

GeoVax, Inc.

@Geovax_News

4 years

HIV Vaccine to be part of a combinational therapy intended to induce remission in HIV-positive individuals #HIV #prevention #vaccine #Phase2 $GOVX

1

3

19

GeoVax, Inc.

@Geovax_News

2 years

Previous peer reviewed publications have validated that the GeoVax constructs of MVA also provide protection against monkeypox. #MVA #validated #safety #durability #vaccine #monkeypox #infectiousdisease $GOVX

0

3

19

GeoVax, Inc.

@Geovax_News

4 years

Ebola virus vaccine is ready to proceed into clinical development, and has demonstrated 100% protection from a single-dose without any adjuvants necessary #Ebola #Virus #Vaccine $GOVX

2

4

19

GeoVax, Inc.

@Geovax_News

4 years

GeoVax HIV vaccines have demonstrated outstanding safety in human clinical trials. #HIV #vaccines #safety #MVA #validated $GOVX

0

14

19

GeoVax, Inc.

@Geovax_News

4 years

Virus Variant From South Africa Detected in US for First Time. GeoVax vaccines produced on the MVA-VLP platform are safe, highly immunogenic, stable at refrigerator temperatures. #Virus #development #SouthAfrica

0

8

19

GeoVax, Inc.

@Geovax_News

5 years

Unlike conventional cancer therapies, cancer vaccines have the potential to induce responses that help control tumors but also establishes immunological memory that can suppress and prevent tumor recurrence. #cancer #vaccines #immunology $GOVX

2

7

16

GeoVax, Inc.

@Geovax_News

4 years

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer #financial #growth #vaccine #development $GOVX

1

8

18

GeoVax, Inc.

@Geovax_News

5 years

Candid, Transparency from the CEO $GOVX Addressing the severe and sharp erosion of GeoVax common stock price and resultant company valuation.

7

16

GeoVax, Inc.

@Geovax_News

4 years

GeoVax continues to progress with Lassa vaccine in non-human primates testing, fully funded by the U.S. Department of Defense. #LassaFever #Epidemiology #InfectiousDisease @GlobalBioD

0

7

16

GeoVax, Inc.

@Geovax_News

2 years

Please Join Us Tomorrow for Second Quarter 2022 Financial Results and Corporate Update #vaccine #COVID19 #immunocompromised #TCells #infectiousdisease #immunotherapy $GOVX

0

6

17

GeoVax, Inc.

@Geovax_News

4 years

GeoVax/NIAID rMVA HIV vaccines have demonstrated outstanding safety in human clinical trials #HIV #immune #response #single -dose #vaccines #infectiousdieases $GOVX

2

11

15

GeoVax, Inc.

@Geovax_News

5 years

Lassa Fever surpasses Ebola, Marburg, and all other hemorrhagic fevers except Dengue, in its public health impact. #Lassafever #vaccineswork @donaldhackett @guirakhoo $GOVX

0

8

16

GeoVax, Inc.

@Geovax_News

5 years

GeoVax has conducted six human trials of the MVA-VLP platform in more than 500 subjects with no serious adverse reactions. GeoVax's MVA-VLP platform and approach is well documented and validated. #humantrials #validation #MVA -VLP #vaccines #cancer $GOVX

0

6

14

GeoVax, Inc.

@Geovax_News

2 years

Vaccine-induced T cells may provide long-term protection against SARS-CoV-2. #COVID19 #vaccine #variants #protection #durability #TCells #immunity $GOVX

6

4

15

GeoVax, Inc.

@Geovax_News

4 years

Ebola virus vaccine is ready to proceed into clinical development, and has demonstrated 100% protection from a single-dose without any adjuvants necessary #Ebola #Virus #Vaccine $GOVX

0

9

14

GeoVax, Inc.

@Geovax_News

3 years

GEO-CM02, a universal SARS-CoV-2 vaccine, encodes the Spike (S), Membrane (M) and Envelope (E) proteins. #COVID -19 #vaccine #universal #singledose $GOVX

1

8

14

GeoVax, Inc.

@Geovax_News

2 years

"A pan-coronavirus vaccine might prevent severe disease and disruption from all variants and subvariants of COVID-19, theoretically eliminating the need for boosters." Source: Fortune #COVID19 #universal #vaccine @ErinMPrater @FortuneMagazine

0

3

15

GeoVax, Inc.

@Geovax_News

4 years

GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients #HIV @UCSF @amfAR #CureAIDS

0

8

15

GeoVax, Inc.

@Geovax_News

2 years

"These data demonstrate single dose protection and potency of the MVA-VLP platform for use in emergency situations to contain outbreaks." Source: npj Vaccines- Nature #vaccine #MVA #outbreaks #SudanEbolavirus #infectiousdisease @NaturePortfolio $GOVX

0

3

14

GeoVax, Inc.

@Geovax_News

2 years

GeoVax is continuing further evaluation of areas to target the use of MVA-based vaccines. #MVA #validated #safety #durability #vaccine #COVID19 #monkeypox #infectiousdisease $GOVX

0

2

15

GeoVax, Inc.

@Geovax_News

5 years

Publication of Lassa Fever Vaccine Study Results First report showing that a single dose of a replication-deﬁcient MVA vector can confer full protection against a lethal challenge. #Lassafever #vaccine $GOVX

0

5

14

GeoVax, Inc.

@Geovax_News

2 years

Join us Today at 4:30pm EST for Q2 2022 Financial Results and Corporate Update #vaccine #COVID19 #immunocompromised #TCells #infectiousdisease #immunotherapy $GOVX

0

3

15

GeoVax, Inc.

@Geovax_News

4 years

MVA was developed specifically for use in humans as a vaccine against smallpox #vaccine #development #smallpox $GOVX

0

6

14

GeoVax, Inc.

@Geovax_News

5 years

GeoVax's Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform technology has been successfully validated in multiple development programs. #HIV #Zika #Ebola #Marburg #Lassafever #infectiousdiseases $GOVX

2

9

12

GeoVax, Inc.

@Geovax_News

2 years

GeoVax is well capitalized to complete its current phase 2 clinical programs, including expansion of the Gedeptin multi-site trial. #Phase2 #clinicaltrials #cancertherapy #Gedeptin #COVD19 #vaccine $GOVX

0

5

13

GeoVax, Inc.

@Geovax_News

3 years

MVA-VLP vaccines are expected to be safe in all target populations including the immunocompromised. #MVA #VLP #vaccine #safety #validated $GOVX

0

5

14

GeoVax, Inc.

@Geovax_News

2 years

Recent Peer-Reviewed Publication Provides Preclinical Data for Vaccine Candidate against Sudan Ebolavirus Showing 100% Protection with a Single Immunization. #vaccine #MVA #SudanEbolavirus #infectiousdisease #singledose @NaturePortfolio $GOVX

0

4

14

GeoVax, Inc.

@Geovax_News

5 years

Cases of deadly coronavirus spike as officials confirm human-to-human spread - the need for vaccines against emerging diseases is never-changing. GeoVax's #MVA -VLP #platform can respond safely and quickly to #epidemics $GOVX #coronavirus

4

12

GeoVax, Inc.

@Geovax_News

5 years

The Global Preparedness Monitoring Board (GPMB) report summary is simple: the world is not prepared for the next pandemic! Working together worldwide in a collaborative, collegial commitment, we can overcome.. #pandemic #vaccines #prevention $GOVX @WHO

0

7

13

GeoVax, Inc.

@Geovax_News

2 years

GeoVax is evaluating additional studies to further validate the potential benefits of GEO-CM04S1, in additional Covid-19 populations and specifically against monkeypox virus. #COVID -19 #vaccines #immunocompromised #MVA #monkeypox #virus $GOVX

0

3

14

GeoVax, Inc.

@Geovax_News

4 years

Doctor who discovered Ebola warns new deadly viruses set to hit mankind as medics fear new Disease X. #Ebola #InfectiousDisease #DiseaseX @MTamfum

0

10

13

GeoVax, Inc.

@Geovax_News

4 years

Video: GeoVax Vaccine has been Selected to Participate in Development of Potential HIV Functional Cure #HIV #functionalcure #vaccine #prevention $GOVX

0

3

14

GeoVax, Inc.

@Geovax_News

4 years

GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq #capitalized #NASDAQ #growth #infectiousdiseases #vaccines #COVID -19 $GOVX

0

6

13

GeoVax, Inc.

@Geovax_News

3 years

Grant funding from the U.S. Department of Defense supports GeoVax's Lassa Fever (LASV) vaccine program. #LassaFever #vaccine #funding @DeptofDefense @genevaUSA $GOVX

1

6

13

GeoVax, Inc.

@Geovax_News

5 years

Currently, there are only a few early clinical stages vectored cancer vaccines being tested in combination with immune checkpoint inhibitors. #cancer #immunotherapy #vaccines #MVA @guirakhoo $GOVX

0

9

12

GeoVax, Inc.

@Geovax_News

2 years

Q3 Highlight: GeoVax has secured the rights from NIH to produce and commercialize Modified Vaccinia Ankara ("MVA") as a vaccine against MPOX and Smallpox. #MPOX #SmallPox #NIH #MVA #vaccine #development $GOVX

0

1

12

GeoVax, Inc.

@Geovax_News

5 years

GOVX- B11 for Clade B #HIV #Prevention is Fully Taxpayer Funded. Shouldn't this Vaccine Candidate be Included in National efforts to Eliminate HIV? Phase II. Ready for Pivotal trials. Ending the HIV Epidemic: A Plan for America @HHSGov @HIVGov $GOVX

6

3

11

GeoVax, Inc.

@Geovax_News

10 days

With cGMP Master Seed Virus of GEO-MVA produced, GeoVax is working to assist in the Mpox global health emergency. Having accomplished this critically important step advances the possibility of expanded #Mpox vaccine supply relative to this emergency. $GOVX

0

5

15

GeoVax, Inc.

@Geovax_News

4 years

Going universal: The search for an all-in-one coronavirus vaccine #MVA #VLP #single -dose #validated $GOVX

3

7

13

GeoVax, Inc.

@Geovax_News

4 years

Patient enrollment for the UCSF, amfAR, AGT and GeoVax collaborative HIV "Functional Cure" clinical trial is expected to commence during late 2020. #COVID -19 #infectiousdiseases #HIV #vaccines $GOVX

0

5

13

GeoVax, Inc.

@Geovax_News

2 months

$GOVX CEO discusses the goal of a more durable vaccine and how the #BARDA award impacts and accelerates that goal. #vaccines #COVID19 #immunocompromised #MVA

Dodd on Project NextGen 3

null

www.youtube.com

1

2

13

GeoVax, Inc.

@Geovax_News

3 years

COVID-19 vaccine highlights: based on MVA-VLP technology which enables insertion of multiple antigen fragments, potentially allowing for broad-spectrum virus prevention #COVID19 #vaccine #IP $GOVX

2

4

13

GeoVax, Inc.

@Geovax_News

5 years

Unlike conventional cancer therapies, cancer vaccines have the potential to induce responses that help control tumors but also establishes immunological memory that can suppress and prevent tumor recurrence. #cancer #vaccines #immunology $GOVX

0

6

12

GeoVax, Inc.

@Geovax_News

2 years

Today! CEO of GeoVax will be presenting at Biotech Showcase 2023. #BiotechShowcase #BiotechShowcase2023 #Phase2 #COVID19 #nextgen #vaccine #immunocompromised #booster #cancertherapy #advancedheadandneckcancer $GOVX

0

11

12

GeoVax, Inc.

@Geovax_News

3 years

MVA vaccines provide surprising level of immunogenicity and protective capacity when compared to replicating VACV vector vaccines expressing the same recombinant genes. #MVA #characteristics #betterway #vaccines

0

9

13

GeoVax, Inc.

@Geovax_News

5 years

Coronavirus Live Updates: More U.S. Cases Emerge, as China's Death Toll Rises #nCoV -2019 #coronavirus will likely continue to spread. This is serious $GOVXD $GOVX @NYTimes

1

8

13

GeoVax, Inc.

@Geovax_News

3 years

Focus is on a single-dose vaccine against multiple COVID-19 variants. #COVID -19 #vaccine #singledose $GOVX

2

5

13

GeoVax, Inc.

@Geovax_News

5 years

New effective vaccines for Lyme disease are coming #LymeDisease #vaccines #greatwork !

0

6

12

GeoVax, Inc.

@Geovax_News

3 years

Join GeoVax at the Inaugural Emerging Growth Virtual Conference - March 17-18, 2021 #vaccine #development #immunooncology @MaximGrp $GOVX

1

5

12

GeoVax, Inc.

@Geovax_News

2 years

MVA is a validated vaccine platform for monkeypox. #MVA #validated #safety #durability #vaccine #monkeypox #infectiousdisease $GOVX

0

2

12

GeoVax, Inc.

@Geovax_News

3 years

GeoVax CEO David Dodd Discusses Universal Coronavirus Vaccine in Development and Clinical Update #vaccine #development #COVID -19 #clinicalupdates @StockNewsNow $GOVX

GeoVax Discusses Universal Coronavirus Vaccine in Development and...

SNNLive caught up with David Dodd, Chairman and CEO of GeoVax Labs, Inc. (NASDAQ: GOVX) via Zoom to discuss (Click the time stamp to jump to each answer, or ...

www.youtube.com

2

6

11

GeoVax, Inc.

@Geovax_News

1 year

$GOVX Announces Issuance of #Ebola Vaccine Patent. The claims encompass multiple ebolavirus strains, including Sudan ebolavirus, Zaire ebolavirus, Taï Forest ebolavirus, and Reston ebolavirus. #vaccines #IP $GOVX

0

3

10

GeoVax, Inc.

@Geovax_News

2 years

GeoVax’s lead infectious disease candidate is being evaluated as a single‐dose COVID‐19 vaccine for immunocompromised patients. #COVID19 #vaccine #infectiousdisease #MVA #immunocompromised $GOVX

0

4

11

GeoVax, Inc.

@Geovax_News

4 years

COVID Vaccines - Not a Sprint - An Ultra Marathon #vaccines #COVID -19 @newsmax @HeatherChilders $GOVX

0

12

10

GeoVax, Inc.

@Geovax_News

2 years

David Dodd discusses GeoVax's unique advantage, the MVA vaccine platform. #vaccine #COVID19 #immunocompromised #variants #MVA @biztv @biztalkradio $GOVX

0

5

11

GeoVax, Inc.

@Geovax_News

5 years

Vaccines are one of our best defenses against global epidemics. But they must be kept cold in order to work🌎 GeoVax's #infectiousdisease #vaccine candidates reduce cold chain storage challenges. #coldchainstorage #vaccines $GOVX @CEPIvaccines @UWEBristol

ADDomer - A new kind of vaccine for untreatable infection

Scientists from the University of Bristol, CNRS and Imophoron Ltd worked with the computer technology giant Oracle to develop a new kind of vaccine that need...

www.youtube.com

4

5

11

GeoVax, Inc.

@Geovax_News

3 years

GeoVax's Presentation at the Benzinga Biotech Small Cap Conference #investorpresentation #infectiousdiseases #vaccines #immuneoncology $GOVX

2

6

12

GeoVax, Inc.

@Geovax_News

2 years

GeoVax's CEO will be presenting updates on their Phase 2 Next-Gen COVID-19 vaccine and their Phase 2 Advanced Head & Neck cancers therapy (Gedeptin™) at Biotech Showcase. #BiotechShowcase #BiotechShowcase2023 #Phase2 #COVID19 #HeadandNeckCancer $GOVX

0

6

11

GeoVax, Inc.

@Geovax_News

5 years

The HPV vaccine is one of only two vaccines that prevent cancer but is underutilized in the US #vaccineswork #cancer #HPV

0

2

12

GeoVax, Inc.

@Geovax_News

5 years

GeoVax Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV #HIV #vaccine #IND $GOVX @americangene

2

4

11

GeoVax, Inc.

@Geovax_News

5 years

HIV “Functional Cure” Immunotherapy #functionalcure #HIV $GOVX $AGTC #cure

1

5

11

GeoVax, Inc.

@Geovax_News

3 years

What Differentiates the four GeoVax Covid-19 Vaccines from DNA and RNA focused products.--The CSO Perspective. #COVID19 #infectiousdiseases #CSO #vaccine $GOVX

1

6

12

GeoVax, Inc.

@Geovax_News

4 years

The GeoVax approach enables the insertion of multiple antigen fragments, potentially allowing for broader spectrum immunity. #vaccine #development #singledose #safety $GOVX

0

8

12

GeoVax, Inc.

@Geovax_News

2 years

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2023 #BiotechShowcase2023 #BiotechShowcase #immunotherapy #COVID19 #vaccines #infectiousdisease $GOVX

0

8

11

GeoVax, Inc.

@Geovax_News

4 years

Scientists liken long Covid symptoms to those of Ebola survivors #COVID19 #symptoms #Ebola

0

4

10

GeoVax, Inc.

@Geovax_News

4 years

GeoVax's most advanced vaccine in the clinic, GOVX‐B11, is designed to protect against the clade B subtype of the HIV virus #vaccine #HIV #virus $GOVX

1

5

11

GeoVax, Inc.

@Geovax_News

4 years

GeoVax Immuno-Oncology Programs: The MVA vector platform is well-suited for development of therapeutic cancer vaccines based on the expression of tumor-associated antigens such as MUC1, Cyclin B1 or others #immunooncology #vaccine #development $GOVX

0

7

11

GeoVax, Inc.

@Geovax_News

4 years

GeoVax recently announced the initiation of a Phase 1 clinical study of a combination therapy in HIV-positive patients utilizing novel boost component MVA62B #HIV #patients #vaccine $GOVX

0

7

11

GeoVax, Inc.

@Geovax_News

3 years

VLPs train the body's immune system to identify and attack an authentic virus. #MVA #VLP #immunesystem #virus $GOVX

0

5

11

GeoVax, Inc.

@Geovax_News

2 years

The MVA vaccine vector is utilized in numerous GeoVax vaccines targeting COVID-19, Hemorrhagic fever viruses, HIV, Zika and the GeoVax MVA-VLP-MUC1 cancer immunotherapy. #MVA #vaccine #COVID19 #infectiousdisease #immunotherapy $GOVX

0

11

GeoVax, Inc.

@Geovax_News

3 years

The GeoVax vaccine technology drives the production of VLPs in the body of the person being vaccinated (in vivo). #MVA #vaccine #development #technology $GOVX

0

3

11

GeoVax, Inc.

@Geovax_News

5 years

Georgia ranks the highest in new diagnoses in the U.S. and third highest in HIV risk. Importantly, a Georgia company, Geovax is preparing its HIV Vaccine for human trials. Look for @Geovax_news at these scientific conferences.

1

3

11

GeoVax, Inc.

@Geovax_News

3 years

The GOVX-B11 vaccine for HIV has demonstrated outstanding safety and immunogenicity. #vaccine #development #HIV #immunogenicity $GOVX

3

5

11

GeoVax, Inc.

@Geovax_News

3 years

There is increasing evidence that alternative COVID-19 vaccine approaches will be necessary to address COVID‐19 and other coronaviruses. #COVID19 #mutations #vaccine #development #safety $GOVX

1

5

11

GeoVax, Inc.

@Geovax_News

5 years

Disease X dummy run: World health experts prepare for a deadly pandemic and its fallout GeoVax's vector platform is perfectly suited to prevent spread of deadly disease X. Safe. Effective. Single Dose. $GOVX

3

5

10

GeoVax, Inc.

@Geovax_News

3 years

Company Updates and Developments for the Infectious Disease and Immuno-Oncology Communities #vaccine #infectiousdisease #immunooncology $GOVX

1

5

10

GeoVax, Inc.

@Geovax_News

4 years

Advancing A Unique Broad-based Vaccine Approach To Fighting COVID-19, Ebola & Beyond - Recording #vaccines #COVID -19 #ebola #infectiousdiseases $GOVX @tribepublic

GeoVax Labs "Advancing A Unique Broad-based Vaccine Approach To...

We hosted Tribe Public's Webinar Presentation and Q&A Event on Wednesday, March 3 (8:30 am PT/ 11:30 am ET) with David A. Dodd, Chairman, President, CEO & Ma...

www.youtube.com

2

6

11

GeoVax, Inc.

@Geovax_News

4 years

Brazil Must Now Contend With Two SARS-CoV-2 Variants at the Same Time #COVID19 #SARS #vaccine #Brazil

0

5

10

GeoVax, Inc.

@Geovax_News

3 years

GeoVax's cancer immunotherapy program is built on the idea of combining a tumor‐associated antigen vaccine with a potent anti‐tumor agent #cancer #tumors #antigens #vaccine $GOVX

0

7

11

GeoVax, Inc.

@Geovax_News

9 days

Importand #Mpox update: $GOVX cGMP Master Seed Virus of GEO-MVA has been produced, and advances the possibility of expanded Mpox vaccine supply.

1

3

12

GeoVax, Inc.

@Geovax_News

4 years

MVA-VLP vaccines induce both humoral (antibody) and cellular (T-cell) immune responses characterized by high magnitude and durability. #MVAVLP #vaccine #antibody #immuneresponse $GOVX

1

5

11

GeoVax, Inc.

@Geovax_News

4 years

GeoVax's recently initiated Phase I study is designed to induce remission in HIV-positive individuals, also known as a “functional cure.” #HIV #patients #vaccine $GOVX

1

3

11

GeoVax, Inc.

@Geovax_News

2 years

GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate against Sudan Ebolavirus Showing 100% Protection with a Single Immunization #vaccine #MVA #SudanEbolavirus #singledose @NaturePortfolio $GOVX

0

4

10

GeoVax, Inc.

@Geovax_News

4 years

GeoVax CEO David Dodd presenting at H.C. Wainwright Global Life Sciences Conference #vaccine #development #MVA #safety #validated @HCWCO $GOVX

1

4

11

GeoVax, Inc.

@Geovax_News

5 years

FDA Clears Next-Gen Assay to Detect HIV-1 Drug Resistance Mutations So much progress is being made! #HIV #diagnostics @dramyabernethy

2

5

10

GeoVax, Inc.

@Geovax_News

5 years

Lassa Fever Vaccine Confers Full-Protection With 1-Dose #Lassa fever cases surpass #Ebola , #Marburg , and all other hemorrhagic fevers except #Dengue , in its public health impact. $GOVX

0

6

11